Eloralintide is a once-weekly injectable selective amylin receptor agonist designed to support significant weight management. By mimicking the natural hormone amylin, it helps reduce appetite, enhance feelings of fullness, slow gastric emptying, and promote greater satiety after meals. This targeted mechanism offers a distinct pathway for meaningful and sustained weight loss, along with potential benefits for overall metabolic health in people with obesity or overweight.
